€
0. 00
0
0%
€
62.81K Market Cap
- P/E Ratio
- Div Yield
748 Volume
-0.37 Eps
€ 0
Previous Close Want to track 7AL0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alligator Bioscience AB (7AL0) Statistics
Valuation metrics
Market Cap 62.81K
Enterprise value -18.98M
Trailing P/E (ttm) 0
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0.12
Price/Book (mrq) 0
Enterprise Value/Revenue -36.93
Enterprise Value/EBITDA 0.16
Overview
Shares outstanding 628.11M
Float 613.86M
Shares short -
% Held by insiders 0.16%
% Held by institutions 0.03%
Average volume (10 days) 21.51K
Average volume (90 days) 8.69K
Price summary
52-Week low 0
52-Week high 0.46
Beta 1.25
50-Day moving average 0.01
200-Day moving average 0.09
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0:1
Last split Date 7 Apr 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -
Operating margin -13.78%
Operational effectiveness
Return on assets -0.63%
Return on equity -7.49%
Income Statement
Revenue (ttm) 514K
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -0.69%
Gross profit (ttm) -
EBITDA -7.61M
Net income to common (ttm) -51.35M
Diluted EPS (ttm) -0.12
Quarterly earnings growth (yoy) -0.99%
Balance Sheet
Total cash (mrq) 32.98M
Total cash per share (mrq) 0.06
Total debt (mrq) 32.38M
Total Debt/Equity (mrq) 78.45
Current ratio (mrq) 1.76%
Book value per share (mrq) -0.21
Cash Flow
Cash flow statement -129.52M
Levered free cash flow (LFCF) -17.32M
